Background/aim: T lymphocytes are important players of the immune response. B-CLL is characterized by several immune defects. Our study aims to characterize the distinct maturational and functional T/NK cell subsets within B-cell chronic lymphocytic leukemia disease Rai stages. Patients and methods: Peripheral blood mononuclear cells from 43 patients enrolled in the study (16 females and 27 males, aged 68±10, 8 Rai 0, 22 Rai 1/2 and 13 Rai 3/4) were analyzed by multiparameter flow cytometry. Distinct subsets within the CD4+ (naive, central memory, effector/peripheral memory, regulatory-Tregs, follicular-TFH, CXCR3+ and/or CCR4+), CD8+ (naive+memory, effector, senescent) and NK (CD57+ and/or CD94+) were identified and compared between disease Rai stages. Results: Total numbers of T lymphocytes increase with disease stage. Both CD4+ and CD8+ T cells are elevated in absolute counts. The majority of CD4+ T cells are antigen-experienced, with increased Tregs, TFH and CXCR3+ (Th1-associated profile) T cell counts. The CD8+ T cells expansion is due mostly to the senescent CD57+ subset. No significant difference within NK subsets was observed among different disease stages. Conclusions: B-CLL behaviour seems to be associated with increased numbers of TFH and Tregs. The therapeutic modulation of T cell response in B-CLL patients may play an important role in the disease behaviour and may be a key event compensating for the immunodeficiency occurring mostly in advanced stages of the disease.
If the inline PDF is not rendering correctly, you can download the PDF file here.
1. Hamblin TJ Oscier DG Young BJ. Autoimmunity in chronic lymphocytic leukaemia. J Clin Pathol. 1986;39(7):713-6.
2. Johnston P Kay N. Pathogenesis of Impaired Cellular Immune Function in CLL. In: Faguet G editor. Chronic Lymphocytic Leukemia. Contemporary Hematology: Humana Press; 2004. p. 109-21.
3. Vuillier F Tortevoye P Binet JL Dighiero G. CD4 CD8 and NK subsets in B-CLL. Nouv Rev Fr Hematol. 1988;30(5-6):331-4.
4. Christopoulos P Pfeifer D Bartholome K Follo M Timmer J Fisch P et al. Definition and characterization of the systemic T-cell dysregulation in untreated indolent Bcell lymphoma and very early CLL. Blood. 2011;117(14):3836-46.
5. Gonzalez-Rodriguez AP Contesti J Huergo-Zapico L Lopez-Soto A Fernandez-Guizan A Acebes-Huerta A et al. Prognostic significance of CD8 and CD4 T cells in chronic lymphocytic leukemia. Leuk Lymphoma. 2010;51(10):1829-36.
6. Catovsky D Miliani E Okos A Galton DA. Clinical significance of T-cells in chronic lymphocytic leukaemia. Lancet. 1974;2(7883):751-2.
7. Herrmann F Lochner A Philippen H Jauer B Ruhl H. Imbalance of T cell subpopulations in patients with chronic lymphocytic leukaemia of the B cell type. Clin Exp Immunol. 1982;49(1):157-62.
8. te Raa GD Tonino SH Remmerswaal EB van Houte AJ Koene HR van Oers MH et al. Chronic lymphocytic leukemia specific T-cell subset alterations are clone-size dependent and not present in monoclonal B lymphocytosis. Leuk Lymphoma. 2012;53(11):2321-5.
9. Mackus WJ Frakking FN Grummels A Gamadia LE De Bree GJ Hamann D et al. Expansion of CMV-specific CD8+CD45RA+CD27- T cells in B-cell chronic lymphocytic leukemia. Blood. 2003;102(3):1057-63.
10. Nunes C Wong R Mason M Fegan C Man S Pepper C. Expansion of a CD8(+)PD-1(+) replicative senescence phenotype in early stage CLL patients is associated with inverted CD4:CD8 ratios and disease progression. Clin Cancer Res. 2012;18(3):678-87.
11. Giannopoulos K M Schmitt PW lstrok. The high frequency of T regulatory cells in patients with B-cell chronic lymphocytic leukemia is diminished through treatment with thalidomide. Leukemia. 2007;22(1):222-4.
12. D’Arena G Laurenti L Minervini MM Deaglio S Bonello L De Martino L et al. Regulatory T-cell number is increased in chronic lymphocytic leukemia patients and correlates with progressive disease. Leuk Res. 2011;35(3):363-8.
13. Kay NE Han L Bone N Williams G. Interleukin 4 content in chronic lymphocytic leukaemia (CLL) B cells and blood CD8+ T cells from B-CLL patients: impact on clonal B-cell apoptosis. Br J Haematol. 2001;112(3):760-7.
14. Mu X Kay NE Gosland MP Jennings CD. Analysis of blood T-cell cytokine expression in B-chronic lymphocytic leukaemia: evidence for increased levels of cytoplasmic IL-4 in resting and activated CD8 T cells. Br J Haematol. 1997;96(4):733-5.
15. Cyster JG. Chemokines and cell migration in secondary lymphoid organs. Science. 1999;286(5447):2098-102.
16. Sallusto F. The role of chemokine receptors in primary effector and memory immune response. Exp Dermatol. 2002;11(5):476-8.
17. Kim CH Rott L Kunkel EJ Genovese MC Andrew DP Wu L et al. Rules of chemokine receptor association with T cell polarization in vivo. J Clin Invest. 2001;108(9):1331-9.
18. Fuss IJ Kanof ME Smith PD Zola H. Isolation of whole mononuclear cells from peripheral blood and cord blood. Curr Protoc Immunol. 2009;Chapter 7:Unit7 1.
19. Ahearne MJ Willimott S Pinon L Kennedy DB Miall F Dyer MJ et al. Enhancement of CD154/IL4 proliferation by the T follicular helper (Tfh) cytokine IL21 and increased numbers of circulating cells resembling Tfh cells in chronic lymphocytic leukaemia. Br J Haematol. 2013;162(3):360 70.
20. Morita R Schmitt N Bentebibel S-E Ranganathan R Bourdery L Zurawski G et al. Human Blood CXCR5(+) CD4(+) T Cells Are Counterparts of T Follicular Cells and Contain Specific Subsets that Differentially Support Antibody Secretion. Immunity. 2011;34(1):108-21.
21. Ma J Zhu C Ma B Tian J Baidoo SE Mao C et al. Increased frequency of circulating follicular helper T cells in patients with rheumatoid arthritis. Clin Dev Immunol. 2012;2012:827480.
22. Lindwall E Gauthier C Lyman J Alarakhia A Zakem J Davis W et al. Circulating T Helper Cells in Patients with Systemic Lupus Erythematosus Share the Phenotypic Property with Lymphoid T Follicular Helper Cells. Nat Immunol. 2010;11(6):464-6.
23. Li X-y Wu Z-b Ding J Zheng Z-h Li X-y Chen Ln et al. Role of the frequency of blood CD4(+) CXCR5(+) CCR6(+) T cells in autoimmunity in patients with Sjögren’s syndrome. Biochem Biophys Res Commun. 2012;422(2):238-44.
24. Piper KP Karanth M McLarnon A Kalk E Khan N Murray J et al. Chronic lymphocytic leukaemia cells drive the global CD4+ T cell repertoire towards a regulatory phenotype and leads to the accumulation of CD4+ forkhead box P3+ T cells. Clin Exp Immunol. 2011;166(2):154-63.
25. Junevik K Werlenius O Hasselblom S Jacobsson S Nilsson-Ehle H Andersson PO. The expression of NK cell inhibitory receptors on cytotoxic T cells in B-cell chronic lymphocytic leukaemia (B-CLL). Ann Hematol. 2007;86(2):89-94.
26. Rivino L Messi M Jarrossay D Lanzavecchia A Sallusto F Geginat J. Chemokine receptor expression identifies pre-T helper (Th) 1 pre-Th2 and nonpolarized cells among human CD4+ central memory T cells. J Exp Med. 2004;200(6):725-35.
27. Podhorecka M Dmoszynska A Rolinski J Wasik E. T type 1/type 2 subsets balance in B-cell chronic lymphocytic leukemia--the three-color flow cytometry analysis. Leuk Res. 2002;26(7):657-60.
28. Rossmann ED Lewin N Jeddi-Tehrani M Osterborg A Mellstedt H. Intracellular T cell cytokines in patients with B cell chronic lymphocytic leukaemia (B-CLL). Eur J Haematol. 2002;68(5):299-306.